GSK PLC (GLAXF)
21.14
+0.14
(+0.67%)
USD |
OTCM |
May 03, 16:00
GSK Market Cap: 86.21B for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 86.21B |
| May 02, 2024 | 85.64B |
| May 01, 2024 | 85.64B |
| April 30, 2024 | 84.82B |
| April 29, 2024 | 86.86B |
| April 26, 2024 | 80.96B |
| April 25, 2024 | 80.96B |
| April 24, 2024 | 80.96B |
| April 23, 2024 | 79.68B |
| April 22, 2024 | 82.80B |
| April 19, 2024 | 82.38B |
| April 18, 2024 | 82.38B |
| April 17, 2024 | 82.38B |
| April 16, 2024 | 82.38B |
| April 15, 2024 | 82.38B |
| April 12, 2024 | 81.85B |
| April 11, 2024 | 83.62B |
| April 10, 2024 | 84.99B |
| April 09, 2024 | 84.99B |
| April 08, 2024 | 84.62B |
| April 05, 2024 | 84.62B |
| April 04, 2024 | 85.23B |
| April 03, 2024 | 85.96B |
| April 02, 2024 | 85.25B |
| April 01, 2024 | 81.97B |
| Date | Value |
|---|---|
| March 28, 2024 | 87.48B |
| March 27, 2024 | 86.62B |
| March 26, 2024 | 86.62B |
| March 25, 2024 | 89.89B |
| March 22, 2024 | 84.34B |
| March 21, 2024 | 85.22B |
| March 20, 2024 | 84.41B |
| March 19, 2024 | 84.51B |
| March 18, 2024 | 85.02B |
| March 15, 2024 | 88.10B |
| March 14, 2024 | 87.05B |
| March 13, 2024 | 87.76B |
| March 12, 2024 | 85.43B |
| March 11, 2024 | 85.43B |
| March 08, 2024 | 87.13B |
| March 07, 2024 | 88.09B |
| March 06, 2024 | 85.87B |
| March 05, 2024 | 85.87B |
| March 04, 2024 | 85.87B |
| March 01, 2024 | 85.22B |
| February 29, 2024 | 85.18B |
| February 28, 2024 | 85.52B |
| February 27, 2024 | 85.52B |
| February 26, 2024 | 87.21B |
| February 23, 2024 | 87.20B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
55.76B
Minimum
Sep 22 2022
118.75B
Maximum
Jan 21 2020
91.27B
Average
95.04B
Median
Apr 13 2020
Market Cap Benchmarks
| Adaptimmune Therapeutics PLC | 293.72M |
| Biodexa Pharmaceuticals Plc | 5.174M |
| Verona Pharma PLC | 1.268B |
| NuCana PLC | 8.458M |
| Autolus Therapeutics PLC | 1.114B |
Market Cap Related Metrics
| PE Ratio | 16.57 |
| PS Ratio | 2.388 |
| Price to Book Value | 4.934 |
| Price to Free Cash Flow | 14.02 |
| Price | 21.14 |
| Earnings Yield | 6.04% |
| Operating PE Ratio | 10.86 |
| Normalized PE Ratio | 15.01 |